000538 云南白药
已收盘 11-06 15:00:00
资讯
新帖
简况
云南白药（000538）11月3日主力资金净卖出3118.87万元
证券之星 · 11-04
云南白药（000538）11月3日主力资金净卖出3118.87万元
【机构调研记录】招商基金调研华润微、云南白药等7只个股（附名单）
证券之星 · 11-03
【机构调研记录】招商基金调研华润微、云南白药等7只个股（附名单）
股市必读：云南白药三季报 - 第三季度单季净利润同比下降2.01%
证券之星 · 11-02
股市必读：云南白药三季报 - 第三季度单季净利润同比下降2.01%
云南白药新注册《茯苓质量视觉检测系统V1.0》项目的软件著作权
证券之星 · 10-31
云南白药新注册《茯苓质量视觉检测系统V1.0》项目的软件著作权
云南白药（000538）披露2026年三季度报告，10月30日股价上涨1.47%
证券之星 · 10-30
云南白药（000538）披露2026年三季度报告，10月30日股价上涨1.47%
云南白药(000538)9月30日股东户数18.84万户，较上期减少0.5%
证券之星 · 10-30
云南白药(000538)9月30日股东户数18.84万户，较上期减少0.5%
图解云南白药三季报：第三季度单季净利润同比下降2.01%
证券之星 · 10-30
图解云南白药三季报：第三季度单季净利润同比下降2.01%
云南白药获得发明专利授权：“一种香砂平胃颗粒指纹图谱及多成分含量的测定方法”
证券之星 · 10-29
云南白药获得发明专利授权：“一种香砂平胃颗粒指纹图谱及多成分含量的测定方法”
10月28日云南白药发生1笔大宗交易 成交金额206.21万元
证券之星 · 10-28
10月28日云南白药发生1笔大宗交易 成交金额206.21万元
云南白药：云南白药胶囊对于上下消化道出血是有止血作用的
证券之星 · 10-27
云南白药：云南白药胶囊对于上下消化道出血是有止血作用的
云南白药（000538）10月20日主力资金净卖出4467.21万元
证券之星 · 10-21
云南白药（000538）10月20日主力资金净卖出4467.21万元
云南白药（000538）10月14日主力资金净买入562.67万元
证券之星 · 10-15
云南白药（000538）10月14日主力资金净买入562.67万元
云南白药MSCI ESG评级上升至AA级
云南白药官微 · 10-13
云南白药MSCI ESG评级上升至AA级
中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜
米内网 · 10-12
中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜
鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达
凤凰网港股 · 10-10
鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达
云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒
证券之星 · 09-29
云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒
云南白药（000538）9月28日主力资金净买入3979.32万元
证券之星 · 09-29
云南白药（000538）9月28日主力资金净买入3979.32万元
股市必读：云南白药（000538）9月24日董秘有最新回复
证券之星 · 09-28
股市必读：云南白药（000538）9月24日董秘有最新回复
云南白药：经营业绩逆势增长
证券之星 · 09-24
云南白药：经营业绩逆势增长
云南白药：应收账款增加主要来源于商业板块
证券之星 · 09-24
云南白药：应收账款增加主要来源于商业板块
加载更多
公司概况
公司名称：
云南白药集团股份有限公司
所属行业：
医药制造业
上市日期：
1993-12-15
主营业务：
云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。
发行价格：
3.38
{"stockData":{"symbol":"000538","market":"SZ","secType":"STK","nameCN":"云南白药","latestPrice":55.14,"timestamp":1793948631000,"preClose":54.76,"halted":0,"volume":8301405,"delay":0,"changeRate":0.0069,"floatShares":1784000000,"shares":1784000000,"eps":2.9137,"marketStatus":"已收盘","change":0.38,"latestTime":"11-06 15:00:00","open":54.5,"high":55.26,"low":54.38,"amount":457000000,"amplitude":0.0161,"askPrice":55.14,"askSize":663,"bidPrice":55.13,"bidSize":231,"shortable":0,"etf":0,"ttmEps":2.9137,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":54.76,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":60.24,"lowLimit":49.28,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1784262603,"isCdr":false,"pbRate":2.43,"roa":"--","peRate":18.924392,"roe":"11.79%","epsLYR":2.89,"committee":-0.649485,"marketValue":98384000000,"turnoverRate":0.0047,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-11-09。","floatMarketCap":98377000000},"requestUrl":"/m/hq/s/000538","defaultTab":"news","newsList":[{"id":"2680702308","title":"云南白药（000538）11月3日主力资金净卖出3118.87万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680702308","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680702308?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:33","pubTimestamp":1793755991,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月3日收盘，云南白药报收于55.6元，上涨2.7%，换手率1.07%，成交量19.11万手，成交额10.57亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入5075.01万元，融资偿还4749.43万元，融资净买入325.58万元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400011722.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0187","BK0188","BK0028","BK0175","LU1807302812.USD","000538","BK0196","BK0164","BK0012","LU1993786604.SGD","BK0239","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680794421","title":"【机构调研记录】招商基金调研华润微、云南白药等7只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2680794421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680794421?lang=zh_cn&edition=full","pubTime":"2026-11-03 08:03","pubTimestamp":1793664186,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月2日披露的机构调研信息，招商基金近期对7家上市公司进行了调研，相关名单如下：1）华润微 调研纪要：目前公司在手订单可覆盖未来6个月以上的产出，部分热门产品待交付周期最高达9个月，晶圆产线保持满载运行。国内Q3收入下滑约15%，主因设备端采购收缩，材料端出货平稳。毛利率前三季度约31.4%，Q3为30.4%，受成本、价格、结构影响，后续有望企稳回升。目前生产经营正常，订单饱和。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300010114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0187","BK0028","000538","BK0196","688396","BK0214","BK0164","BK0239","BK0175","LU1993786604.SGD","LU1807302812.USD","LU2187417386.USD","LU1960683339.HKD","LU2351347302.SGD","BK0012","LU2929501877.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680207210","title":"股市必读：云南白药三季报 - 第三季度单季净利润同比下降2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680207210","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680207210?lang=zh_cn&edition=full","pubTime":"2026-11-02 03:23","pubTimestamp":1793560990,"startTime":"0","endTime":"0","summary":"第三季度单季度主营收入103.73亿元，同比上升10.38%；归母净利润11.21亿元，同比下降2.01%；扣非净利润11.12亿元，同比上升2.15%；负债率26.49%，投资收益7.86亿元，财务费用2838.64万元，毛利率29.13%。公司公告汇总2026年三季度报告2026年第三季度营业收入10,372,987,344.38元，同比增长10.38%；归属于上市公司股东的净利润1,121,182,700.53元，同比下降2.01%。年初至报告期末营业收入32,257,063,315.53元，同比增长5.23%；归属于上市公司股东的净利润4,822,353,319.20元，同比增长0.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200000857.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679102240","title":"云南白药新注册《茯苓质量视觉检测系统V1.0》项目的软件著作权","url":"https://stock-news.laohu8.com/highlight/detail?id=2679102240","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679102240?lang=zh_cn&edition=full","pubTime":"2026-10-31 04:47","pubTimestamp":1793393270,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药（000538）新注册了《茯苓质量视觉检测系统V1.0》项目的软件著作权。今年以来云南白药新注册软件著作权11个。结合公司2026年中报财务数据，今年上半年公司在研发方面投入了1.9亿元，同比增21.6%。通过天眼查大数据分析，云南白药集团股份有限公司共对外投资了34家企业，参与招投标项目20944次；财产线索方面有商标信息3307条，专利信息615条，著作权信息90条；此外企业还拥有行政许可1361个。数据来源：企查查以上内容为证券之星据公开信息整理，不构成投资建议。相关 ETF","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100008594.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0028","BK0239","159180","BK0188","BK0012","LU1807302812.USD","LU1960683339.HKD","BK0164","BK0187","BK0196","LU1993786604.SGD","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679216866","title":"云南白药（000538）披露2026年三季度报告，10月30日股价上涨1.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679216866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679216866?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:42","pubTimestamp":1793360541,"startTime":"0","endTime":"0","summary":"截至2026年10月30日收盘，云南白药报收于53.71元，较前一交易日上涨1.47%，最新总市值为958.33亿元。云南白药于2026年10月30日披露《2026年三季度报告》。报告显示，本报告期营业收入10,372,987,344.38元，同比增长10.38%；归属于上市公司股东的净利润1,121,182,700.53元，同比下降2.01%。年初至报告期末营业收入32,257,063,315.53元，同比增长5.23%；归属于上市公司股东的净利润4,822,353,319.20元，同比增长0.95%。总资产54,859,658,209.33元，归属于上市公司股东的所有者权益40,269,650,060.88元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000048707.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538","BK0012","BK0187","LU1960683339.HKD","BK0175","BK0196","LU1993786604.SGD","BK0239","BK0164","BK0188","LU1807302812.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679958213","title":"云南白药(000538)9月30日股东户数18.84万户，较上期减少0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679958213","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679958213?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:16","pubTimestamp":1793358977,"startTime":"0","endTime":"0","summary":"证券之星消息，近日云南白药披露，截至2026年9月30日公司股东户数为18.84万户，较6月30日减少947.0户，减幅为0.5%。在中药行业个股中，云南白药股东户数高于行业平均水平，截至9月30日，中药行业平均股东户数为5.33万户。从股价来看，2026年6月30日至2026年9月30日，云南白药区间涨幅为8.68%，在此期间股东户数减少947.0户，减幅为0.5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000047068.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1960683339.HKD","BK0188","BK0175","BK0187","LU1993786604.SGD","000538","BK0239","BK0164","BK0028","LU1807302812.USD","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679323892","title":"图解云南白药三季报：第三季度单季净利润同比下降2.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679323892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679323892?lang=zh_cn&edition=full","pubTime":"2026-10-30 02:45","pubTimestamp":1793299543,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药2026年三季报显示，前三季度公司主营收入322.57亿元，同比上升5.23%；归母净利润48.22亿元，同比上升0.95%；扣非净利润46.31亿元，同比上升1.78%；其中2026年第三季度，公司单季度主营收入103.73亿元，同比上升10.38%；单季度归母净利润11.21亿元，同比下降2.01%；单季度扣非净利润11.12亿元，同比上升2.15%；负债率26.49%，投资收益7.86亿元，财务费用2838.64万元，毛利率29.13%。财报数据概要请见下图:本文数据来源于云南白药2026年三季报，仅供参考不构成投资建议。相关 ETF","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000005510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679140400","title":"云南白药获得发明专利授权：“一种香砂平胃颗粒指纹图谱及多成分含量的测定方法”","url":"https://stock-news.laohu8.com/highlight/detail?id=2679140400","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679140400?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:11","pubTimestamp":1793275914,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示云南白药新获得一项发明专利授权，专利名为“一种香砂平胃颗粒指纹图谱及多成分含量的测定方法”，专利申请号为CN202611055656.2，授权日为2026年10月23日。本发明解决了香砂平胃颗粒化学成分复杂、各成分色谱峰易互相干扰、难以全面对药品质量进行管控的技术问题，可更加有效地控制香砂平胃颗粒质量。今年以来云南白药新获得专利授权24个，较去年同期减少了14.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900053111.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0175","LU1960683339.HKD","000538","BK0187","LU1993786604.SGD","BK0239","BK0012","BK0164","BK0196","LU1807302812.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678682174","title":"10月28日云南白药发生1笔大宗交易 成交金额206.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2678682174","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678682174?lang=zh_cn&edition=full","pubTime":"2026-10-28 18:18","pubTimestamp":1793182732,"startTime":"0","endTime":"0","summary":"证券之星消息，10月28日云南白药发生大宗交易，交易数据如下：大宗交易成交价格53.01元，成交3.89万股，成交金额206.21万元，买方营业部为机构专用，卖方营业部为机构专用。近三个月该股共发生1笔大宗交易，合计成交389.0手。该股近期无解禁股上市。截至2026年10月28日收盘，云南白药(000538)报收于53.01元，下跌0.79%，换手率0.45%，成交量7.97万手，成交额4.23亿元。该股最近90天内共有7家机构给出评级，买入评级5家，增持评级2家；过去90天内机构目标均价为65.59。本文数据来源于深圳证券交易所大宗交易信息披露，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102800039443.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","BK0239","000538","BK0164","BK0187","LU1807302812.USD","BK0012","BK0175","LU1993786604.SGD","BK0188","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678122902","title":"云南白药：云南白药胶囊对于上下消化道出血是有止血作用的","url":"https://stock-news.laohu8.com/highlight/detail?id=2678122902","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2678122902?lang=zh_cn&edition=full","pubTime":"2026-10-27 17:18","pubTimestamp":1793092687,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)10月27日在投资者关系平台上答复投资者关心的问题。投资者提问：公司云南白药胶囊对上下消化道出血不管用是什么原因？胶囊说明书上说是可以止血药的？云南白药回复：您好！云南白药胶囊对于上下消化道出血是有止血作用的，已有很多指南共识、文献可以证明。但是对于个体来说，需要结合出血原因，合并云南白药胶囊来进行治疗，比如胃溃疡，还需要针对病因，进行针对性的抗幽门螺旋杆菌、保护溃疡面的药物合用，才能达到标本兼治的效果。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102700032249.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","LU1960683339.HKD","LU1993786604.SGD","BK0187","BK0239","000538","BK0188","BK0164","BK0175","BK0196","BK0028","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677439356","title":"云南白药（000538）10月20日主力资金净卖出4467.21万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677439356","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677439356?lang=zh_cn&edition=full","pubTime":"2026-10-21 09:19","pubTimestamp":1792545549,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月20日收盘，云南白药报收于53.38元，下跌1.49%，换手率0.65%，成交量11.54万手，成交额6.16亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入2882.91万元，融资偿还4289.26万元，融资净偿还1406.35万元。融券方面，融券卖出4800.0股，融券偿还1.22万股，融券余量446.93万股，融券余额2.39亿元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100008453.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","000538","BK0012","LU1960683339.HKD","BK0188","LU1993786604.SGD","LU1807302812.USD","BK0187","BK0196","BK0164","BK0239","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675376757","title":"云南白药（000538）10月14日主力资金净买入562.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2675376757","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675376757?lang=zh_cn&edition=full","pubTime":"2026-10-15 09:08","pubTimestamp":1792026495,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月14日收盘，云南白药报收于52.65元，上涨1.27%，换手率0.58%，成交量10.39万手，成交额5.46亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入3582.48万元，融资偿还4494.37万元，融资净偿还911.89万元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101500008066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0012","BK0028","LU1993786604.SGD","BK0239","BK0175","LU1807302812.USD","BK0196","BK0188","BK0187","BK0164","000538","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675356069","title":"云南白药MSCI ESG评级上升至AA级","url":"https://stock-news.laohu8.com/highlight/detail?id=2675356069","media":"云南白药官微","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675356069?lang=zh_cn&edition=full","pubTime":"2026-10-13 18:46","pubTimestamp":1791888360,"startTime":"0","endTime":"0","summary":"近日，国际权威指数机构摩根士丹利资本国际公司公布的最新ESG评级结果显示，云南白药集团股份有限公司MSCI的ESG评级从A级上升至AA级，创历史新高，跻身医药行业及云南省上市公司的领先梯队。云南白药已连续六年保持MSCI ESG评级A级及以上，本次评级提升标志着公司在环境、社会及公司治理领域的管理绩效获得国际评级机构的高度认可。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-13/doc-inivasec7299575.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["PRXI","000538","IVRA","159717","USXF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674873664","title":"中成药“药王”跌超13%！21个独家品种强势突围，云南白药、济川起飞，以岭、华润三九霸榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2674873664","media":"米内网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674873664?lang=zh_cn&edition=full","pubTime":"2026-10-12 16:27","pubTimestamp":1791793620,"startTime":"0","endTime":"0","summary":"销售额排名中，“三强”地位稳固，济川、扬子江独家品种起飞；增长方面冰火两重天，8个品种大跌超20%，13个品种逆势涨逾10%。中成药销售额TOP20中，阿胶、安宫牛黄丸、感冒灵颗粒稳居前三。其中，济川药业的独家品种蒲地蓝消炎口服液同比大涨14.71%，提升8个位次；扬子江药业的独家品种蓝芩口服液提升6个位次，云南白药的独家品种云南白药气雾剂提升3个位次等。13个中成药涨逾10%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-10-12/doc-iniuyarc5366137.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0175","000999","000538","BK0239","BK0183","BK0185","BK0188","LU1807302812.USD","LU1960683339.HKD","LU1993786604.SGD","BK0196","BK0012","BK0010","BK0164","BK0060","BK0187","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674481868","title":"鸟巢唱响“声命力”，气血与音乐同频——云南白药独家冠名周深鸟巢演唱会，以音乐共鸣探索健康理念年轻化表达","url":"https://stock-news.laohu8.com/highlight/detail?id=2674481868","media":"凤凰网港股","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674481868?lang=zh_cn&edition=full","pubTime":"2026-10-10 22:21","pubTimestamp":1791642060,"startTime":"0","endTime":"0","summary":"云南白药作为本次演唱会的独家冠名品牌，与数万\"生米\"共度了一场以音乐为名的中秋之约。当《想见到气血满满的你》在鸟巢唱响、全场齐声合唱，“气血声命力”也从一句传播主张，变成了万人同频的真实共鸣。一内一外之间，气血健康的认知被揉进了年轻人的日常。品牌也将生日应援延伸至城市空间，云南白药分别在长沙、昆明打造周深生日主题楼体，为歌迷提供共同庆生、打卡留念的场景。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MzU5ODU1Mjg5Nw==&mid=2247836552&idx=3&sn=8503b4ade8e08090779b6ef285e1f149&chksm=ff1b4e4ea273d8b6ba9498c20d8e2684b0170c3af1e6e13666ae1ca96ceda829501bc28841ca&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU1807302812.USD","LU1993786604.SGD","BK0012","PEJ","LU1960683339.HKD","BK0028","BK0239","000538","BK0196","BK0187","BK0188","BK0164","BK0175"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671299435","title":"云南白药营收净利创新高难掩增速滑坡，商业毛利率跌破6%，第二曲线有增长尚难接棒","url":"https://stock-news.laohu8.com/highlight/detail?id=2671299435","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671299435?lang=zh_cn&edition=full","pubTime":"2026-09-29 15:15","pubTimestamp":1790666123,"startTime":"0","endTime":"0","summary":"若剔除此项后，上半年归属净利润同比增长8.33%，二季度增速达到13.18%。证券之星注意到，尽管2026年上半年云南白药的营收、利润指标均创历史新高，但增速明显放缓。2023年中报，云南白药营收突破200亿元的规模，营收增幅12.73%，归属净利润增幅更是达88.47%。2024年上半年、2025年上半年，云南白药的营收增幅分别为0.72%、3.92%，归属净利润分别增长12.76%、13.93%，今年上半年归属净利润增速骤降至个位数。此外，云南白药布局创新药领域。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/SS2026092900019976.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671690602","title":"云南白药（000538）9月28日主力资金净买入3979.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671690602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671690602?lang=zh_cn&edition=full","pubTime":"2026-09-29 09:08","pubTimestamp":1790644126,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，云南白药报收于50.33元，上涨0.92%，换手率0.39%，成交量6.99万手，成交额3.51亿元。近5日资金流向一览见下表：云南白药融资融券信息显示，融资方面，当日融资买入1412.67万元，融资偿还1670.75万元，融资净偿还258.07万元。云南白药主营业务：自制工业品的研发、生产和销售,以及药品批发零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092900008281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","LU1807302812.USD","BK0196","LU1960683339.HKD","BK0175","LU1993786604.SGD","BK0028","BK0239","000538","BK0187","BK0188","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670409569","title":"股市必读：云南白药（000538）9月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2670409569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670409569?lang=zh_cn&edition=full","pubTime":"2026-09-28 01:25","pubTimestamp":1790529911,"startTime":"0","endTime":"0","summary":"截至2026年9月24日收盘，云南白药报收于49.87元，下跌0.89%，换手率0.39%，成交量6.94万手，成交额3.47亿元。董秘： 尊敬的投资者您好，截至2026年二季度末，公司股东总数为189,362人。截至2026年二季度末，公司应收账款余额101.83亿元，环比一季度下降14.57%，同比2025年二季度末下降3.15%。云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800000841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1993786604.SGD","LU1807302812.USD","BK0164","000538","LU1960683339.HKD","BK0196","BK0175","BK0187","BK0012","BK0239","BK0028","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669842466","title":"云南白药：经营业绩逆势增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2669842466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669842466?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:18","pubTimestamp":1790241499,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药09月24日在投资者关系平台上答复投资者关心的问题。公司锚定战略规划，持续做精主业，用不断提升的运营管理能力应对外部市场的不确定性，经营业绩逆势增长，实现了“增长、增效、增值”的既定目标。云南白药长期投资价值突出，当前股价波动主要受宏观市场环境、市场资金偏好等外部因素影响，存在一定不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029609.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0196","LU1807302812.USD","BK0164","000538","BK0239","LU1993786604.SGD","LU1960683339.HKD","BK0012","BK0175","BK0188","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669668184","title":"云南白药：应收账款增加主要来源于商业板块","url":"https://stock-news.laohu8.com/highlight/detail?id=2669668184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669668184?lang=zh_cn&edition=full","pubTime":"2026-09-24 17:15","pubTimestamp":1790241311,"startTime":"0","endTime":"0","summary":"证券之星消息，云南白药(000538)09月24日在投资者关系平台上答复投资者关心的问题。投资者提问：公司26年1季报，应收账款大幅增加20亿的原因是什么，是赚的净利润都没有收回来吗？云南白药回复：您好！公司应收账款增加主要来源于商业板块，该板块主要覆盖云南省内公立医院，客户信用较好、应收账款风险较小。截至2026年二季度末，公司应收账款余额101.83亿元，环比一季度下降14.57%，同比2025年二季度末下降3.15%。未来公司将持续强化客户信用全流程闭环管理，有效控制应收账款风险。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。相关 ETF责任编辑：刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400029522.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0164","BK0187","000538","BK0239","LU1960683339.HKD","BK0028","BK0175","LU1993786604.SGD","BK0188","BK0196","LU1807302812.USD","BK0012"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794041173716,"stockEarnings":[{"period":"1week","weight":0.0266},{"period":"1month","weight":0.0932},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.0695},{"period":"1year","weight":0.0371},{"period":"ytd","weight":0.021}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"云南白药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"188415人(较上一季度减少0.50%)","perCapita":"9469股","listingDate":"1993-12-15","address":"云南省昆明市呈贡区云南白药街3686号","registeredCapital":"178426万元","survey":" 云南白药集团股份有限公司的主营业务是药品、健康品、中药资源的研发、生产及销售。公司的主要产品是工业产品（自制）、批发零售、农产品。公司第17年上榜财富中文网发布的《财富中国500强排行榜》，位列第366位；入选美国《制药经理人》杂志《全球制药企业50强排行榜》，位列第33位。","listedPrice":3.38},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"云南白药,000538,云南白药股票,云南白药股票老虎,云南白药股票老虎国际,云南白药行情,云南白药股票行情,云南白药股价,云南白药股市,云南白药股票价格,云南白药股票交易,云南白药股票购买,云南白药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"云南白药(000538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供云南白药(000538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}